Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver

Type 2 diabetes mellitus (T2D) is a metabolic disorder caused by chronic hyperglycemia due to a deficiency in the secretion and/or action of insulin. Zinc (Zn) supplementation and strength exercise increases insulin signaling. We evaluate the effect of Zn supplementation and strength exercise on ins...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biological trace element research 2021-06, Vol.199 (6), p.2215-2224
Hauptverfasser: Vivero, Ariel, Ruz, Manuel, Rivera, Matías, Miranda, Karen, Sacristán, Camila, Espinosa, Alejandra, Codoceo, Juana, Inostroza, Jorge, Vásquez, Karla, Pérez, Álvaro, García-Díaz, Diego, Arredondo, Miguel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2224
container_issue 6
container_start_page 2215
container_title Biological trace element research
container_volume 199
creator Vivero, Ariel
Ruz, Manuel
Rivera, Matías
Miranda, Karen
Sacristán, Camila
Espinosa, Alejandra
Codoceo, Juana
Inostroza, Jorge
Vásquez, Karla
Pérez, Álvaro
García-Díaz, Diego
Arredondo, Miguel
description Type 2 diabetes mellitus (T2D) is a metabolic disorder caused by chronic hyperglycemia due to a deficiency in the secretion and/or action of insulin. Zinc (Zn) supplementation and strength exercise increases insulin signaling. We evaluate the effect of Zn supplementation and strength exercise on insulin resistance in the liver of rats with diet-induced T2D through the study of phosphorylation of Akt and protein tyrosine phosphatase 1B (PTP1B). Rats were fed with a high-fat diet (HFD) for 18 weeks to induce T2D and then assigned in four experimental groups: HFD, HFD-Zn (Zn), HFD-strength exercise (Ex), and HFD-Zn/strength exercise (ZnEx) and treated during 12 weeks. Serum Zn, lipid profile, transaminases, glucose, and insulin were measured. In the liver with/without insulin stimuli, total and phosphorylated Akt (pAkt Ser473 ) and PTP1B (pPTP1B Ser50 ) were determined by western blot. Hepatic steatosis was evaluated by histological staining with red oil and intrahepatic triglyceride (IHTG) content. There were no differences in biochemical and body-related variables. The ZnEx group showed a higher level of pAkt, both with/without insulin. The ZnEx group also showed higher levels of pPTP1B with respect to HFD and Zn groups. The ZnEx group had higher levels of pPTP1B than groups treated with insulin. Liver histology showed a better integrity and less IHTG in Ex and ZnEx with respect to the HFD group. The Ex and ZnEx groups had lower IHTG with respect to the HFD group. Our results showed that Zn supplementation and strength exercise together improved insulin signaling and attenuated nonalcoholic liver disease in a T2D rat model.
doi_str_mv 10.1007/s12011-020-02324-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2443885174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2443885174</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-2fee627f963180d3078db906ce15b601eadc775ff295cb331d4657177c43d6fb3</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EokPhBVggS2zYBPwbJ-za0gLSCEZ02LCxHOem45Kxg-0As-XJMU0BiQUL60r2-T5bPgg9puQ5JUS9SJQRSivCSFmciYrfQSsqZVsRxchdtCK05pVoG3GEHqR0TQhVrOX30REvo60FX6Efn5y3-HKephH24LPJLnhsfI8vcwR_lXf4_DtE6xJg5_EHkxP-5sru9jABZviVMx1kSC_xyed8k9tsN_QUb3YhTbsQD-PSWLLvgjejDbswOosvTM4HvHZfIT5E9wYzJnh0O4_Rx4vz7dmbav3-9duzk3VluZK5YgNAzdTQ1pw2pOdENX3XktoClV1NKJjeKiWHgbXSdpzTXtRSUaWs4H09dPwYPVt6pxi-zJCy3rtkYRyNhzAnzYTgTSOpEgV9-g96HeZYnl8oSUWjyv_TQrGFsjGkFGHQU3R7Ew-aEv3LkF4M6WJI3xjSvISe3FbP3R76P5HfSgrAFyCVI38F8e_d_6n9CaokmvY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2514871001</pqid></control><display><type>article</type><title>Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Vivero, Ariel ; Ruz, Manuel ; Rivera, Matías ; Miranda, Karen ; Sacristán, Camila ; Espinosa, Alejandra ; Codoceo, Juana ; Inostroza, Jorge ; Vásquez, Karla ; Pérez, Álvaro ; García-Díaz, Diego ; Arredondo, Miguel</creator><creatorcontrib>Vivero, Ariel ; Ruz, Manuel ; Rivera, Matías ; Miranda, Karen ; Sacristán, Camila ; Espinosa, Alejandra ; Codoceo, Juana ; Inostroza, Jorge ; Vásquez, Karla ; Pérez, Álvaro ; García-Díaz, Diego ; Arredondo, Miguel</creatorcontrib><description>Type 2 diabetes mellitus (T2D) is a metabolic disorder caused by chronic hyperglycemia due to a deficiency in the secretion and/or action of insulin. Zinc (Zn) supplementation and strength exercise increases insulin signaling. We evaluate the effect of Zn supplementation and strength exercise on insulin resistance in the liver of rats with diet-induced T2D through the study of phosphorylation of Akt and protein tyrosine phosphatase 1B (PTP1B). Rats were fed with a high-fat diet (HFD) for 18 weeks to induce T2D and then assigned in four experimental groups: HFD, HFD-Zn (Zn), HFD-strength exercise (Ex), and HFD-Zn/strength exercise (ZnEx) and treated during 12 weeks. Serum Zn, lipid profile, transaminases, glucose, and insulin were measured. In the liver with/without insulin stimuli, total and phosphorylated Akt (pAkt Ser473 ) and PTP1B (pPTP1B Ser50 ) were determined by western blot. Hepatic steatosis was evaluated by histological staining with red oil and intrahepatic triglyceride (IHTG) content. There were no differences in biochemical and body-related variables. The ZnEx group showed a higher level of pAkt, both with/without insulin. The ZnEx group also showed higher levels of pPTP1B with respect to HFD and Zn groups. The ZnEx group had higher levels of pPTP1B than groups treated with insulin. Liver histology showed a better integrity and less IHTG in Ex and ZnEx with respect to the HFD group. The Ex and ZnEx groups had lower IHTG with respect to the HFD group. Our results showed that Zn supplementation and strength exercise together improved insulin signaling and attenuated nonalcoholic liver disease in a T2D rat model.</description><identifier>ISSN: 0163-4984</identifier><identifier>EISSN: 1559-0720</identifier><identifier>DOI: 10.1007/s12011-020-02324-3</identifier><identifier>PMID: 32939643</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>AKT protein ; Animals ; Biochemistry ; Biomedical and Life Sciences ; Biotechnology ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 - metabolism ; Diet ; Diet, High-Fat ; Dietary Supplements ; Evaluation ; Fatty liver ; High fat diet ; Histology ; Hyperglycemia ; Insulin ; Insulin - metabolism ; Insulin Resistance ; Life Sciences ; Lipids ; Liver ; Liver - metabolism ; Liver diseases ; Metabolic disorders ; Non-alcoholic Fatty Liver Disease - metabolism ; Nutrition ; Oncology ; Phosphatase ; Phosphorylation ; Physical Conditioning, Animal ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism ; Protein-tyrosine-phosphatase ; Proto-Oncogene Proteins c-akt - metabolism ; Rats ; Secretion ; Serum ; Signaling ; Steatosis ; Strength ; Triglycerides ; Tyrosine ; Zinc ; Zinc - metabolism ; Zinc - pharmacology</subject><ispartof>Biological trace element research, 2021-06, Vol.199 (6), p.2215-2224</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-2fee627f963180d3078db906ce15b601eadc775ff295cb331d4657177c43d6fb3</citedby><cites>FETCH-LOGICAL-c375t-2fee627f963180d3078db906ce15b601eadc775ff295cb331d4657177c43d6fb3</cites><orcidid>0000-0002-6277-4090</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12011-020-02324-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12011-020-02324-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32939643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vivero, Ariel</creatorcontrib><creatorcontrib>Ruz, Manuel</creatorcontrib><creatorcontrib>Rivera, Matías</creatorcontrib><creatorcontrib>Miranda, Karen</creatorcontrib><creatorcontrib>Sacristán, Camila</creatorcontrib><creatorcontrib>Espinosa, Alejandra</creatorcontrib><creatorcontrib>Codoceo, Juana</creatorcontrib><creatorcontrib>Inostroza, Jorge</creatorcontrib><creatorcontrib>Vásquez, Karla</creatorcontrib><creatorcontrib>Pérez, Álvaro</creatorcontrib><creatorcontrib>García-Díaz, Diego</creatorcontrib><creatorcontrib>Arredondo, Miguel</creatorcontrib><title>Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver</title><title>Biological trace element research</title><addtitle>Biol Trace Elem Res</addtitle><addtitle>Biol Trace Elem Res</addtitle><description>Type 2 diabetes mellitus (T2D) is a metabolic disorder caused by chronic hyperglycemia due to a deficiency in the secretion and/or action of insulin. Zinc (Zn) supplementation and strength exercise increases insulin signaling. We evaluate the effect of Zn supplementation and strength exercise on insulin resistance in the liver of rats with diet-induced T2D through the study of phosphorylation of Akt and protein tyrosine phosphatase 1B (PTP1B). Rats were fed with a high-fat diet (HFD) for 18 weeks to induce T2D and then assigned in four experimental groups: HFD, HFD-Zn (Zn), HFD-strength exercise (Ex), and HFD-Zn/strength exercise (ZnEx) and treated during 12 weeks. Serum Zn, lipid profile, transaminases, glucose, and insulin were measured. In the liver with/without insulin stimuli, total and phosphorylated Akt (pAkt Ser473 ) and PTP1B (pPTP1B Ser50 ) were determined by western blot. Hepatic steatosis was evaluated by histological staining with red oil and intrahepatic triglyceride (IHTG) content. There were no differences in biochemical and body-related variables. The ZnEx group showed a higher level of pAkt, both with/without insulin. The ZnEx group also showed higher levels of pPTP1B with respect to HFD and Zn groups. The ZnEx group had higher levels of pPTP1B than groups treated with insulin. Liver histology showed a better integrity and less IHTG in Ex and ZnEx with respect to the HFD group. The Ex and ZnEx groups had lower IHTG with respect to the HFD group. Our results showed that Zn supplementation and strength exercise together improved insulin signaling and attenuated nonalcoholic liver disease in a T2D rat model.</description><subject>AKT protein</subject><subject>Animals</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diet</subject><subject>Diet, High-Fat</subject><subject>Dietary Supplements</subject><subject>Evaluation</subject><subject>Fatty liver</subject><subject>High fat diet</subject><subject>Histology</subject><subject>Hyperglycemia</subject><subject>Insulin</subject><subject>Insulin - metabolism</subject><subject>Insulin Resistance</subject><subject>Life Sciences</subject><subject>Lipids</subject><subject>Liver</subject><subject>Liver - metabolism</subject><subject>Liver diseases</subject><subject>Metabolic disorders</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Nutrition</subject><subject>Oncology</subject><subject>Phosphatase</subject><subject>Phosphorylation</subject><subject>Physical Conditioning, Animal</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism</subject><subject>Protein-tyrosine-phosphatase</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Rats</subject><subject>Secretion</subject><subject>Serum</subject><subject>Signaling</subject><subject>Steatosis</subject><subject>Strength</subject><subject>Triglycerides</subject><subject>Tyrosine</subject><subject>Zinc</subject><subject>Zinc - metabolism</subject><subject>Zinc - pharmacology</subject><issn>0163-4984</issn><issn>1559-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc1u1DAURi0EokPhBVggS2zYBPwbJ-za0gLSCEZ02LCxHOem45Kxg-0As-XJMU0BiQUL60r2-T5bPgg9puQ5JUS9SJQRSivCSFmciYrfQSsqZVsRxchdtCK05pVoG3GEHqR0TQhVrOX30REvo60FX6Efn5y3-HKephH24LPJLnhsfI8vcwR_lXf4_DtE6xJg5_EHkxP-5sru9jABZviVMx1kSC_xyed8k9tsN_QUb3YhTbsQD-PSWLLvgjejDbswOosvTM4HvHZfIT5E9wYzJnh0O4_Rx4vz7dmbav3-9duzk3VluZK5YgNAzdTQ1pw2pOdENX3XktoClV1NKJjeKiWHgbXSdpzTXtRSUaWs4H09dPwYPVt6pxi-zJCy3rtkYRyNhzAnzYTgTSOpEgV9-g96HeZYnl8oSUWjyv_TQrGFsjGkFGHQU3R7Ew-aEv3LkF4M6WJI3xjSvISe3FbP3R76P5HfSgrAFyCVI38F8e_d_6n9CaokmvY</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Vivero, Ariel</creator><creator>Ruz, Manuel</creator><creator>Rivera, Matías</creator><creator>Miranda, Karen</creator><creator>Sacristán, Camila</creator><creator>Espinosa, Alejandra</creator><creator>Codoceo, Juana</creator><creator>Inostroza, Jorge</creator><creator>Vásquez, Karla</creator><creator>Pérez, Álvaro</creator><creator>García-Díaz, Diego</creator><creator>Arredondo, Miguel</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QH</scope><scope>7QP</scope><scope>7TN</scope><scope>7U7</scope><scope>7UA</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H97</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L.G</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6277-4090</orcidid></search><sort><creationdate>20210601</creationdate><title>Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver</title><author>Vivero, Ariel ; Ruz, Manuel ; Rivera, Matías ; Miranda, Karen ; Sacristán, Camila ; Espinosa, Alejandra ; Codoceo, Juana ; Inostroza, Jorge ; Vásquez, Karla ; Pérez, Álvaro ; García-Díaz, Diego ; Arredondo, Miguel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-2fee627f963180d3078db906ce15b601eadc775ff295cb331d4657177c43d6fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>AKT protein</topic><topic>Animals</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diet</topic><topic>Diet, High-Fat</topic><topic>Dietary Supplements</topic><topic>Evaluation</topic><topic>Fatty liver</topic><topic>High fat diet</topic><topic>Histology</topic><topic>Hyperglycemia</topic><topic>Insulin</topic><topic>Insulin - metabolism</topic><topic>Insulin Resistance</topic><topic>Life Sciences</topic><topic>Lipids</topic><topic>Liver</topic><topic>Liver - metabolism</topic><topic>Liver diseases</topic><topic>Metabolic disorders</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Nutrition</topic><topic>Oncology</topic><topic>Phosphatase</topic><topic>Phosphorylation</topic><topic>Physical Conditioning, Animal</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism</topic><topic>Protein-tyrosine-phosphatase</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Rats</topic><topic>Secretion</topic><topic>Serum</topic><topic>Signaling</topic><topic>Steatosis</topic><topic>Strength</topic><topic>Triglycerides</topic><topic>Tyrosine</topic><topic>Zinc</topic><topic>Zinc - metabolism</topic><topic>Zinc - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vivero, Ariel</creatorcontrib><creatorcontrib>Ruz, Manuel</creatorcontrib><creatorcontrib>Rivera, Matías</creatorcontrib><creatorcontrib>Miranda, Karen</creatorcontrib><creatorcontrib>Sacristán, Camila</creatorcontrib><creatorcontrib>Espinosa, Alejandra</creatorcontrib><creatorcontrib>Codoceo, Juana</creatorcontrib><creatorcontrib>Inostroza, Jorge</creatorcontrib><creatorcontrib>Vásquez, Karla</creatorcontrib><creatorcontrib>Pérez, Álvaro</creatorcontrib><creatorcontrib>García-Díaz, Diego</creatorcontrib><creatorcontrib>Arredondo, Miguel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Aqualine</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Oceanic Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Water Resources Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Biological trace element research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vivero, Ariel</au><au>Ruz, Manuel</au><au>Rivera, Matías</au><au>Miranda, Karen</au><au>Sacristán, Camila</au><au>Espinosa, Alejandra</au><au>Codoceo, Juana</au><au>Inostroza, Jorge</au><au>Vásquez, Karla</au><au>Pérez, Álvaro</au><au>García-Díaz, Diego</au><au>Arredondo, Miguel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver</atitle><jtitle>Biological trace element research</jtitle><stitle>Biol Trace Elem Res</stitle><addtitle>Biol Trace Elem Res</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>199</volume><issue>6</issue><spage>2215</spage><epage>2224</epage><pages>2215-2224</pages><issn>0163-4984</issn><eissn>1559-0720</eissn><abstract>Type 2 diabetes mellitus (T2D) is a metabolic disorder caused by chronic hyperglycemia due to a deficiency in the secretion and/or action of insulin. Zinc (Zn) supplementation and strength exercise increases insulin signaling. We evaluate the effect of Zn supplementation and strength exercise on insulin resistance in the liver of rats with diet-induced T2D through the study of phosphorylation of Akt and protein tyrosine phosphatase 1B (PTP1B). Rats were fed with a high-fat diet (HFD) for 18 weeks to induce T2D and then assigned in four experimental groups: HFD, HFD-Zn (Zn), HFD-strength exercise (Ex), and HFD-Zn/strength exercise (ZnEx) and treated during 12 weeks. Serum Zn, lipid profile, transaminases, glucose, and insulin were measured. In the liver with/without insulin stimuli, total and phosphorylated Akt (pAkt Ser473 ) and PTP1B (pPTP1B Ser50 ) were determined by western blot. Hepatic steatosis was evaluated by histological staining with red oil and intrahepatic triglyceride (IHTG) content. There were no differences in biochemical and body-related variables. The ZnEx group showed a higher level of pAkt, both with/without insulin. The ZnEx group also showed higher levels of pPTP1B with respect to HFD and Zn groups. The ZnEx group had higher levels of pPTP1B than groups treated with insulin. Liver histology showed a better integrity and less IHTG in Ex and ZnEx with respect to the HFD group. The Ex and ZnEx groups had lower IHTG with respect to the HFD group. Our results showed that Zn supplementation and strength exercise together improved insulin signaling and attenuated nonalcoholic liver disease in a T2D rat model.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32939643</pmid><doi>10.1007/s12011-020-02324-3</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-6277-4090</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0163-4984
ispartof Biological trace element research, 2021-06, Vol.199 (6), p.2215-2224
issn 0163-4984
1559-0720
language eng
recordid cdi_proquest_miscellaneous_2443885174
source MEDLINE; SpringerNature Journals
subjects AKT protein
Animals
Biochemistry
Biomedical and Life Sciences
Biotechnology
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - metabolism
Diet
Diet, High-Fat
Dietary Supplements
Evaluation
Fatty liver
High fat diet
Histology
Hyperglycemia
Insulin
Insulin - metabolism
Insulin Resistance
Life Sciences
Lipids
Liver
Liver - metabolism
Liver diseases
Metabolic disorders
Non-alcoholic Fatty Liver Disease - metabolism
Nutrition
Oncology
Phosphatase
Phosphorylation
Physical Conditioning, Animal
Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism
Protein-tyrosine-phosphatase
Proto-Oncogene Proteins c-akt - metabolism
Rats
Secretion
Serum
Signaling
Steatosis
Strength
Triglycerides
Tyrosine
Zinc
Zinc - metabolism
Zinc - pharmacology
title Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T06%3A06%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zinc%20Supplementation%20and%20Strength%20Exercise%20in%20Rats%20with%20Type%202%20Diabetes:%20Akt%20and%20PTP1B%20Phosphorylation%20in%20Nonalcoholic%20Fatty%20Liver&rft.jtitle=Biological%20trace%20element%20research&rft.au=Vivero,%20Ariel&rft.date=2021-06-01&rft.volume=199&rft.issue=6&rft.spage=2215&rft.epage=2224&rft.pages=2215-2224&rft.issn=0163-4984&rft.eissn=1559-0720&rft_id=info:doi/10.1007/s12011-020-02324-3&rft_dat=%3Cproquest_cross%3E2443885174%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2514871001&rft_id=info:pmid/32939643&rfr_iscdi=true